Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

A+H Listing: The Connect Inclusion Stat and the Trade

HK A+H IPO 2026 Update: Cornerstone Signal Returns, A-Share Momentum

HSCI / HK Connect Inclusion (Mar 2026): Lessons from a Sep 2025 Retrospective Event Study

HSCI / Hong Kong Connect Inclusion (March 2026): A Preliminary Assessment

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Event-Driven

<ul>
<li>Hang Seng Index Company announced HSCI review results after market close on Feb 13. In our previous note, we reviewed the Sep 2025 HK Connect cycle.</li>
<li>In this note, we provide an update on the forecasted upcoming implementation action by the mainland exchanges based on implementation rules and highlight stock performance thus far.</li>
<li>Our analysis suggests that selectivity will be critical in this cycle, with differentiation driven by pre-positioning, narrative alignment, and ownership structure rather than mechanical inclusion alone.</li>
</ul>


Hang Seng Index Company announced HSCI review results after market close on Feb 13. In our previous note, we reviewed the Sep 2025 HK Connect cycle.
In this note, we provide an update on the forecasted upcoming implementation action by the mainland exchanges based on implementation rules and highlight stock performance thus far.
Our analysis suggests that selectivity will be critical in this cycle, with differentiation driven by pre-positioning, narrative alignment, and ownership structure rather than mechanical inclusion alone.


Yangtze Optical Fibre and Cable (6869 HK)

China Resources Medical Holdings (1515 HK)

Nickel Resources International Holdings (2889 HK)

Beijing Capital International Airport (694 HK)

Yuexiu Real Estate Investment Trust (405 HK)

Bright Smart Securities & Commodities (1428 HK)

Global New Material International (6616 HK)

Hao Tian International Construction Investment (1341 HK)

Hao Tian International Construction Investment

HK Connect March 2026: Implementation Forecast and Positioning Framework

Insilico Medicine

HK Connect March 2026: Implementation Forecast and Positioning Framework